25-Hydroxycholecalciferol for Early Neonatal Hypocalcemia
1978
Fleischman, Alan R. | Rosen, John F. | Nathenson, Gerald
Extract: Oral 25-hydroxycholecalciferol (25OHDsub3) has been used to prevent early neonatal hypocalcemia. Thirty premature neonates were studied prospectively from birth: 22 premature infants constituted a control group, and eight were treated orally with 25OHDsub3 (2 micro g/kg/day) for five days beginning within the first 12 hours of life. Eleven of the 22 premature infants in the control group became hypocalcemic. Only one of the eight premature infants treated with 25OHDsub3 became hypocalcemic. In treated neonates, serum 25-hydroxy-vitamin D, as well as serum Ca++ and Ca (sub t) levels, increased during the first five days of life and were considerably greater than levels in control neonates. No untoward effects of this treatment were observed.
显示更多 [+] 显示较少 [-]